ACHV vs POM: fair value comparison
Achieve Life Sciences, Inc. and Pomdoctor Limited · Updated 2026-10-19
ACHV has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. POM reports in CNY, so no same-currency fair-value verdict is published for it. Within Healthcare, POM currently ranks higher by quality score.
| ACHV | POM | |
|---|---|---|
| Verdict | No estimate yet | Awaiting full valuation |
| Last price | $6.38 | $0.92 |
| 12-month range | $2.65–$8.53 | $0.55–$109.62 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #291 of 301 Healthcare | #290 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Low |
| Margin trend | Contracting | Contracting |
| Revenue growth | — | Declining |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Mixed | — |
| 52-week position | The upper-middle quarter | The bottom quarter |
Full single-stock breakdowns: ACHV fair value analysis · POM fair value analysis